IXHL
Incannex Healthcare Ltd ADRNASDAQHEALTHCAREDRUG MANUFACTURERS - SPECIALTY & GENERIC
Key Statistics
Market Cap
$42.12M
P/E Ratio
—
EPS
$-16.62
Beta
2.95
52W High
$49.80
52W Low
$2.49
50-Day MA
$3.63
200-Day MA
$9.67
Dividend Yield
—
Profit Margin
0.00%
Forward P/E
3.91
PEG Ratio
—
About Incannex Healthcare Ltd ADR
Incannex Healthcare Limited is engaged in the research, development and sale of medicinal cannabinoid products in Australia. The company is headquartered in Sydney, Australia.
Fundamentals
| Revenue (TTM) | 0 |
| Gross Profit (TTM) | 0 |
| EBITDA | $-24.70M |
| Operating Margin | 0.00% |
| Return on Equity | -117.20% |
| Return on Assets | -32.20% |
| Revenue/Share (TTM) | $0.00 |
| Book Value | $5.50 |
| Price-to-Book | 0.56 |
| Price-to-Sales (TTM) | 7764.11 |
| EV/Revenue | 1654.74 |
| EV/EBITDA | -5.13 |
| Quarterly Earnings Growth (YoY) | 0.00% |
| Quarterly Revenue Growth (YoY) | -100.00% |
| Shares Outstanding | $11.96M |
| Float | $10.71M |
| % Insiders | 12.34% |
| % Institutions | 12.06% |
More HEALTHCARE Stocks
Data last updated: 5/25/2026